Page last updated: 2024-08-26

vinpocetine and Dementia, Vascular

vinpocetine has been researched along with Dementia, Vascular in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gupta, S; Sharma, B; Sharma, BM; Singh, P	1
Balogh, A; Fehér, G; Késmárky, G; Misnyovszky, M; Nagy, K; Németh, G; Németh, GY; Szapáry, L; Tóth, K; Tóth, T	1
Szatmari, SZ; Whitehouse, PJ	1
Valikovics, A	1
Chiba, K; Nozaki, Y; Sasaki, K; Tohgi, H	1

Reviews

2 review(s) available for vinpocetine and Dementia, Vascular

Article	Year
[Vinpocetin in neurological diseases]. Ideggyogyaszati szemle, 2012, Nov-30, Volume: 65, Issue:11-12 Topics: Animals; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition; Cognition Disorders; Dementia, Vascular; Hemorheology; Humans; Microcirculation; Nervous System Diseases; Neuroprotective Agents; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids	2012
Vinpocetine for cognitive impairment and dementia. The Cochrane database of systematic reviews, 2003, Issue:1 Topics: Alzheimer Disease; Cognition Disorders; Dementia; Dementia, Vascular; Humans; Nootropic Agents; Randomized Controlled Trials as Topic; Vinca Alkaloids	2003

Article

Year

[Vinpocetin in neurological diseases].

Ideggyogyaszati szemle, 2012, Nov-30, Volume: 65, Issue:11-12

Topics: Animals; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition; Cognition Disorders; Dementia, Vascular; Hemorheology; Humans; Microcirculation; Nervous System Diseases; Neuroprotective Agents; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids

2012

Vinpocetine for cognitive impairment and dementia.

The Cochrane database of systematic reviews, 2003, Issue:1

Topics: Alzheimer Disease; Cognition Disorders; Dementia; Dementia, Vascular; Humans; Nootropic Agents; Randomized Controlled Trials as Topic; Vinca Alkaloids

2003

Trials

1 trial(s) available for vinpocetine and Dementia, Vascular

Article	Year
[Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions]. Ideggyogyaszati szemle, 2007, Jul-30, Volume: 60, Issue:7-8 Topics: Administration, Oral; Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dementia, Vascular; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Nootropic Agents; Pilot Projects; Psychometrics; Severity of Illness Index; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids	2007

Article

Year

[Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].

Ideggyogyaszati szemle, 2007, Jul-30, Volume: 60, Issue:7-8

Topics: Administration, Oral; Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dementia, Vascular; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Nootropic Agents; Pilot Projects; Psychometrics; Severity of Illness Index; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids

2007

Other Studies

2 other study(ies) available for vinpocetine and Dementia, Vascular

Article	Year
Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia. Current neurovascular research, 2015, Volume: 12, Issue:3 Topics: Acetamides; Acetylcholinesterase; Analysis of Variance; Animals; Arterial Occlusive Diseases; Brain; Catalase; Dementia, Vascular; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Male; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Superoxide Dismutase; Time Factors; Vinca Alkaloids	2015
Effect of vinpocetine on oxygen release of hemoglobin and erythrocyte organic polyphosphate concentrations in patients with vascular dementia of the Binswanger type. Arzneimittel-Forschung, 1990, Volume: 40, Issue:6 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aged; Dementia, Vascular; Diphosphoglyceric Acids; Erythrocytes; Female; Hemoglobins; Humans; Hydrogen-Ion Concentration; Male; Oxygen; Polyphosphates; Vinca Alkaloids	1990

Article

Year

Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia.

Current neurovascular research, 2015, Volume: 12, Issue:3

Topics: Acetamides; Acetylcholinesterase; Analysis of Variance; Animals; Arterial Occlusive Diseases; Brain; Catalase; Dementia, Vascular; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Male; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Superoxide Dismutase; Time Factors; Vinca Alkaloids

2015

Effect of vinpocetine on oxygen release of hemoglobin and erythrocyte organic polyphosphate concentrations in patients with vascular dementia of the Binswanger type.

Arzneimittel-Forschung, 1990, Volume: 40, Issue:6

Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aged; Dementia, Vascular; Diphosphoglyceric Acids; Erythrocytes; Female; Hemoglobins; Humans; Hydrogen-Ion Concentration; Male; Oxygen; Polyphosphates; Vinca Alkaloids

1990